From: Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation
Contaminated PF (n = 101) | Non-contaminated PF (n = 189) | |
---|---|---|
Donor | ||
Age, years | 61.3 ± 13.9 | 59.7 ± 15.3 |
Cold ischemia time, h | 16.4 ± 3.8 | 15.8 ± 4.2 |
Recipient | ||
Age, years | 55.7 ± 11.6 | 54.8 ± 11.5 |
Sex (M/F) | 69/32 | 129/60 |
Induction ID, No. (%) | ||
Thymoglobulin | 7 (7) | 3 (1) |
Basiliximab | 100 (99) | 186 (98) |
Rituximab | 2 (2) | 0 |
Maintenance ID, No. (%) | ||
Tacrolimus | 88 (87.1) | 142 (75.1) |
Cyclosporine | 9 (8) | 35 (18) |
Mycophenolate mofetil | 77 (76.2) | 133 (70.3) |
Everolimus | 5 (5) | 17 (9) |
Azathoprine | 0 | 3 (1) |
Steroids | 98 (97) | 182 (96.3) |